---
title: "GSK and Amgen to add medicines to TrumpRx, Fox Business reports"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279101674.md"
description: "March 13 (Reuters) - GSK and Amgen ( AMGN ) will add their medicines to TrumpRX, the prescription drug website launched by President Donald Trump's administration, Fox Business reported on Friday. (Reporting by Ismail Shakil and Costas Pitas; Editing by Chris Reese)"
datetime: "2026-03-13T23:47:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279101674.md)
  - [en](https://longbridge.com/en/news/279101674.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279101674.md)
---

# GSK and Amgen to add medicines to TrumpRx, Fox Business reports

March 13 (Reuters) - GSK and Amgen ( AMGN ) will add their medicines to TrumpRX, the prescription drug website launched by President Donald Trump's administration, Fox Business reported on Friday. (Reporting by Ismail Shakil and Costas Pitas; Editing by Chris Reese)

### Related Stocks

- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Revolution Medicines Says Daraxonrasib Shows Improvement In Survival In Late-Stage Pancreatic Cancer Study](https://longbridge.com/en/news/282550417.md)
- [GSK's Chronic Rhinosinusitis Drug Lands Approval in China](https://longbridge.com/en/news/281986143.md)
- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)](https://longbridge.com/en/news/281838022.md)
- [Key facts: GSK’s Mo‑Rez 62%/67% responses; alpibectir in Phase‑2b and Phase‑2 meningitis](https://longbridge.com/en/news/282607697.md)